NASDAQ:GWPH - GW Pharmaceuticals PLC- SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$170.40 +2.29 (+1.36 %)
(As of 03/20/2019 04:00 PM ET)
Previous Close$168.11
Today's Range$166.77 - $171.88
52-Week Range$90.14 - $182.23
Volume329,937 shs
Average Volume516,769 shs
Market Capitalization$5.14 billion
P/E Ratio-16.14
Dividend YieldN/A
Beta2.81

SEC Filings

GW Pharmaceuticals PLC- (NASDAQ:GWPH) SEC Filings

DateFilerForm TypeView
03/19/2019
6:00 PM
Gover Justin D. (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/18/2019
9:40 AM
GW Pharmaceuticals PLC- (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/15/2019
8:23 PM
GW Pharmaceuticals PLC- (Issuer)
Secor Alicia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/15/2019
8:16 PM
Brown Cabot (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/15/2019
8:15 PM
GW Pharmaceuticals PLC- (Issuer)
MACKEY CATHERINE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:13 PM
George Adam D. (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:10 PM
GW Pharmaceuticals PLC- (Issuer)
Secor Alicia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:09 PM
Brown Cabot (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:08 PM
GW Pharmaceuticals PLC- (Issuer)
Snyder Douglas B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:08 PM
GW Pharmaceuticals PLC- (Issuer)
MACKEY CATHERINE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:07 PM
Gover Justin D. (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:07 PM
GW Pharmaceuticals PLC- (Issuer)
Tovey Christopher J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:06 PM
GW Pharmaceuticals PLC- (Issuer)
Knappertz Volker (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:05 PM
GW Pharmaceuticals PLC- (Issuer)
Noble James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:05 PM
GUY GEOFFREY W DR (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:05 PM
GW Pharmaceuticals PLC- (Issuer)
Waldegrave William A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:04 PM
GW Pharmaceuticals PLC- (Issuer)
Lynch Thomas G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2019
8:03 PM
Giacobello Scott M. (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2019
7:01 PM
GUY GEOFFREY W DR (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2019
4:09 PM
Gangolli Julian S (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2019
4:05 PM
GW Pharmaceuticals PLC- (Issuer)
Knappertz Volker (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2019
4:02 PM
Gover Justin D. (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/26/2019
3:26 PM
GW Pharmaceuticals PLC- (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/15/2019
3:31 PM
Gover Justin D. (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2019
2:24 PM
GW Pharmaceuticals PLC- (Subject)
SCOPIA CAPITAL MANAGEMENT LP (Filed by)
Form SC 13G/A
View Filing
01/18/2019
4:01 PM
GW Pharmaceuticals PLC- (Filer)
Form S-3ASR
View Filing
01/07/2019
5:13 AM
GW Pharmaceuticals PLC- (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/26/2018
3:15 PM
Gover Justin D. (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/28/2018
7:58 PM
GW Pharmaceuticals PLC- (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
11/27/2018
3:05 PM
GW Pharmaceuticals PLC- (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/26/2018
3:15 PM
GW Pharmaceuticals PLC- (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/23/2018
3:30 PM
George Adam D. (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/05/2018
4:08 PM
GW Pharmaceuticals PLC- (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/03/2018
4:30 PM
GW Pharmaceuticals PLC- (Filer)
Form 424B5
View Filing
10/01/2018
3:14 PM
GW Pharmaceuticals PLC- (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/01/2018
3:12 PM
GW Pharmaceuticals PLC- (Filer)
Form 424B5
View Filing
09/30/2018
11:00 PM
George Adam D. (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
Giacobello Scott M. (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
Brown Cabot (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
Gangolli Julian S (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
Gover Justin D. (Reporting)
GW Pharmaceuticals PLC- (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
GW Pharmaceuticals PLC- (Issuer)
Lynch Thomas G (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
GW Pharmaceuticals PLC- (Issuer)
Tovey Christopher J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
GW Pharmaceuticals PLC- (Issuer)
Snyder Douglas B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
GW Pharmaceuticals PLC- (Issuer)
MACKEY CATHERINE J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
GW Pharmaceuticals PLC- (Issuer)
Secor Alicia (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
GW Pharmaceuticals PLC- (Issuer)
Noble James (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
GW Pharmaceuticals PLC- (Issuer)
Waldegrave William A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
GW Pharmaceuticals PLC- (Issuer)
Knappertz Volker (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
GW Pharmaceuticals PLC- (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/27/2018
10:19 AM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/24/2018
5:09 AM
GW Pharmaceuticals PLC- (Filer)
Form 8-A12B/A
View Filing
09/21/2018
4:16 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/07/2018
3:01 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/25/2018
3:30 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/11/2018
3:13 PM
GW Pharmaceuticals PLC- (Subject)
SCOPIA CAPITAL MANAGEMENT LP (Filed by)
Form SC 13G/A
View Filing
05/24/2018
3:05 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/08/2018
3:09 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/19/2018
3:55 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/19/2018
5:05 AM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/06/2018
4:04 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/03/2018
3:41 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/14/2018
9:51 AM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/13/2018
3:52 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/06/2018
3:07 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/23/2018
11:50 AM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/14/2018
3:06 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/14/2018
10:35 AM
GW Pharmaceuticals PLC- (Subject)
M&G INVESTMENT MANAGEMENT LTD (Filed by)
Form SC 13G/A
View Filing
02/13/2018
8:38 AM
FMR LLC (Filed by)
GW Pharmaceuticals PLC- (Subject)
Form SC 13G/A
View Filing
02/05/2018
3:44 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/08/2018
3:05 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/21/2017
10:57 AM
GW Pharmaceuticals PLC- (Filer)
Form CT ORDER
View Filing
12/08/2017
2:21 PM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/08/2017
5:16 AM
GW Pharmaceuticals PLC- (Filer)
Form 424B5
View Filing
12/05/2017
4:29 PM
GW Pharmaceuticals PLC- (Filer)
Form 424B5
View Filing
12/04/2017
6:02 AM
GW Pharmaceuticals PLC- (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
View Filing
12/04/2017
6:00 AM
GW Pharmaceuticals PLC- (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Featured Article: 12b-1 Fees

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel